Regional News Archives - Page 76 of 190 - Journal for Clinical Studies

Current Edition

Regional News

Merck, Eisai’s 007 goes down as Keytruda-Lenvima combo fails in newly diagnosed lung cancer

Merck & Co. isn’t resting on Keytruda’s laurels. But an attempt to improve on the undoubtful cancer immunotherapy king with another agent has failed in a 007 miss...

13 December 2021 Regional News checkpoint inhibitors | combination therapy

Continue Reading →

Regional News

Lawmakers blast pharma for ‘outrageous’ prices and ‘anticompetitive conduct’ in culmination of 3-year probe

For years, drugmakers have targeted "weaknesses" in the U.S. healthcare system to reap dividends on older meds, The House Oversight Committee said Friday. The "outra...

13 December 2021 Regional News diabetes | drug costs

Continue Reading →

Regional News

After its $7.6B buyout fell through, Sobi scores NICE backing for rare disease drug Aspaveli

After rare disease drugmaker Sobi reportedly had a buyout scuppered by pharma giant AstraZeneca, the company has picked up a win that stands to bolster its Aspaveli l...

10 December 2021 Regional News Aspaveli | disease

Continue Reading →

Regional News

J&J celebrates nurses with a new campaign in wake of burnout plaguing the profession

Nurses deserve more than just a “thank you” for all they contribute to the medical profession and the patients they care for, but Johnson & Johnson knows that app...

10 December 2021 Regional News burnout | campaign

Continue Reading →

Regional News

AstraZeneca’s Evusheld becomes first FDA-authorized COVID antibody to protect the immunocompromised before exposure

People in the U.S. with conditions that prevent them from building immunity with COVID-19 vaccines will soon have a way to get adequate protection from the virus. Wi...

10 December 2021 Regional News AstraZeneca | COVID

Continue Reading →

Regional News

Pfizer, BioNTech say omicron partially evades its COVID vaccine but booster can restore protection

The COVID-19 vaccine produced by Pfizer and BioNTech, Comirnaty, provides less protection against the omicron variant than it did against wild-type COVID and other va...

10 December 2021 Regional News BioNTech | booster

Continue Reading →

Regional News

BD seals the deal to acquire UK-based surgical sealant maker Tissuemed

After chalking up half a dozen tuck-in acquisitions throughout its fiscal year 2021—which ended Sept. 30—BD seems poised to outdo itself in 2022. It’s already off to...

10 December 2021 Regional News acquisition | BD

Continue Reading →

Regional News

ASH: Senti Bio’s gene circuit CAR-NK cell therapy enhances cancer killing and safety in leukemia models

Engineered cell therapy has revolutionized the treatment of blood cancers, but precisely selecting the right target to kill off cancer cells while sparing healthy cel...

10 December 2021 Regional News cancer | CAR-NK

Continue Reading →

Regional News

Totus tots up $40M in series A funding to go after competitive cancer space

Totus Medicines is making a play for the PI3Kα inhibitor market. Exiting stealth with a $40 million series A round, the Massachusetts-based biotech plans to advance a...

10 December 2021 Regional News biotech | cancer

Continue Reading →

Regional News

AbbVie’s Rinvoq, Pfizer’s Xeljanz and Lilly’s Olumiant slapped with new FDA warnings amid JAK safety crackdown

The second regulatory shoe has finally dropped for AbbVie, Pfizer and Eli Lilly amid the safety review of JAK inhibitors for inflammatory diseases. But confirmed labe...

8 December 2021 Regional News AbbVie | atopic dermatitis

Continue Reading →